[
  {
    "sentence": "The ELISA assay indicated that HSPB1 knockdown led to decreased IL6 secretion while HSPB1 overexpression promoted the secretion of IL6 (Fig. 7A).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The supernatants from HSPB1 overexpressing cells led to increased migration ability of breast cancer cells and tube formation of HUVECs, while the supplement of IL6 neutralizing antibodies could partly attenuate the promoted effect (Fig. 7B).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "As shown in Fig. 8A–C, HSPB1 overexpression led to increased tumor volume and tumor weight.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Moreover, the tumors in the doxorubicin-injected mice were smaller and lighter than those in PBS-treated mice (Fig. 8A–C), indicating the suppressive effect of doxorubicin on the growth of breast cancer in vivo.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Significantly, the tumors in the doxorubicin-injected mice bearing HSPB1-overexpressing cells were significantly larger and heavier compared to those in doxorubicin-injected mice implanted with control cells (Fig. 8A–C), suggesting that overexpression of HSPB1 attenuated the anti-tumor effect of doxorubicin.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "No significant body weight loss occurred during the treatment (Fig. 8D), excluding the drug-related toxicities.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel D",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel D",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel D",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "HE staining was used to evaluate the morphology of the tumors (Fig. 8E).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The IHC analysis indicated that the expression changes of IKβ-α, NF-κB, and its target genes in the tumor tissues were consistent with the findings in vitro (Fig. 8E).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Also, IHC staining of 4-HNE confirmed that DOX enhanced lipid peroxidation in tumor tissue, while HSPB1 could significantly suppress it (Fig. 8E).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Moreover, doxorubicin decreased the protein expression of Ki-67, which was enhanced by HSPB1 overexpression (Fig. 8E).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The lung metastatic burden was significantly higher in HSPB1-overexpressing mice, in which the number of metastatic mice and lung metastatic foci was increased compared to those in control group (Fig. 8F–H).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel F",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Hematoxylin and eosin (H&E) staining was used to pathologically confirm the metastatic nodule in the dissected lungs, and overexpression of HSPB1 significantly increased the size and number of lung metastatic nodules (Fig. 8F–H).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel F",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Collectively, these results suggested that HSPB1 facilitated tumor growth, doxorubicin resistance, and metastasis in vivo (Fig. 8I).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel I",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel I",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel I",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "As shown in Fig. 8A–C, HSPB1 overexpression led to increased tumor volume and tumor weight.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Moreover, the tumors in the doxorubicin-injected mice were smaller and lighter than those in PBS-treated mice (Fig. 8A–C), indicating the suppressive effect of doxorubicin on the growth of breast cancer in vivo.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Significantly, the tumors in the doxorubicin-injected mice bearing HSPB1-overexpressing cells were significantly larger and heavier compared to those in doxorubicin-injected mice implanted with control cells (Fig. 8A–C), suggesting that overexpression of HSPB1 attenuated the anti-tumor effect of doxorubicin.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "No significant body weight loss occurred during the treatment (Fig. 8D), excluding the drug-related toxicities.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel D",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel D",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel D",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "HE staining was used to evaluate the morphology of the tumors (Fig. 8E).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The IHC analysis indicated that the expression changes of IKβ-α, NF-κB, and its target genes in the tumor tissues were consistent with the findings in vitro (Fig. 8E).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Also, IHC staining of 4-HNE confirmed that DOX enhanced lipid peroxidation in tumor tissue, while HSPB1 could significantly suppress it (Fig. 8E).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Moreover, doxorubicin decreased the protein expression of Ki-67, which was enhanced by HSPB1 overexpression (Fig. 8E).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The lung metastatic burden was significantly higher in HSPB1-overexpressing mice, in which the number of metastatic mice and lung metastatic foci was increased compared to those in control group (Fig. 8F–H).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel F",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Hematoxylin and eosin (H&E) staining was used to pathologically confirm the metastatic nodule in the dissected lungs, and overexpression of HSPB1 significantly increased the size and number of lung metastatic nodules (Fig. 8F–H).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel F",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Collectively, these results suggested that HSPB1 facilitated tumor growth, doxorubicin resistance, and metastasis in vivo (Fig. 8I).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel I",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel I",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel I",
        "figure_key": "figure_8"
      }
    ]
  }
]